Background illustration for clinical trials search

Paid Clinical Trials Oakland

Discover 2,299 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

for
HER2-positive Breast Cancer
Location: San Francisco CA, Sacramento CA, Clovis CA, Gilbert AZ,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07413939

Phase 2, Phase 3, Recruiting

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors, Advanced Breast Cancer
Location: San Francisco CA, Newport Beach CA, Seattle WA,
Sponsor: Ensem Therapeutics

Sex: All

Age: 18+

Code: NCT06993844

Phase 1, Phase 2, Recruiting

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

for
Prostate Cancer
Location: San Francisco CA, Madison WI, Ann Arbor MI, Durham NC
Sponsor: Duke University

Sex: Male

Age: 18+

Code: NCT07050433

Recruiting

A Study of ZL-1310 in Participants With Selected Solid Tumors

for
Solid Tumors
Location: San Francisco CA, Dallas TX, McAllen TX, Houston TX,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06885281

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

for
Breast Cancer
Location: San Francisco CA, Duarte CA, Irvine CA, Eugene OR,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07100106

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: San Francisco CA, Westwood, Los Angeles CA,
Sponsor: Fore Biotherapeutics

Sex: All

Age: 8+

Code: NCT05503797

Phase 2, Recruiting

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

for
Oncology, MEK Mutation, RAF Gene Mutation,
Location: San Francisco CA, Westwood, Los Angeles CA, Houston TX,
Sponsor: Nested Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06326411

Phase 1, Recruiting

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

for
Prostate Adenocarcinoma
Location: San Francisco CA, Fresno CA, Portland OR, Milwaukee WI,
Sponsor: Alessa Therapeutics Inc.

Sex: Male

Age: 21+

Code: NCT06257693

Phase 1, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: San Francisco CA, Palo Alto CA, Santa Monica CA,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase 1, Recruiting

ATEMPT 2.0: Adjuvant T-DM1 vs TH

for
Breast Cancer, HER2-positive Breast Cancer
Location: San Francisco CA, Houston TX, Chicago IL, Nashville TN,
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT04893109

Phase 2, Recruiting

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

for
Advanced Solid Tumors With KRAS G12C Mutations,
Location: San Francisco CA, La Jolla CA, San Antonio TX,
Sponsor: Frontier Medicines Corporation

Sex: All

Age: 18+

Code: NCT06244771

Phase 1, Phase 2, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: San Francisco CA, Santa Rosa CA, Stockton CA,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase 2, Phase 3, Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: San Francisco CA, Palo Alto CA, Bakersfield CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase 3, Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

for
Urothelial Carcinoma
Location: San Francisco CA, Templeton CA, San Luis Obispo CA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04879329

Phase 2, Recruiting

"Vasectomy: Right for Me?" Decision Support Tool

for
Vasectomy, Contraception, Contraception Behavior,
Location: San Francisco CA, Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: Male

Age: 21 - 55

Code: NCT07451067

Recruiting

Sperm Preparation Prior to Intrauterine Insemination Study

for
Infertility, Infertility Secondary, Infertility Unexplained,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT05693220

Recruiting

The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over

for
Depression, Mild Cognitive Impairment
Location: Sacramento CA, Miami FL
Sponsor: Miro Health

Sex: All

Age: 60+

Code: NCT06011681

Recruiting

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

for
Neovascular Age-related Macular Degeneration
Location: San Francisco CA, Mountain View CA, Campbell CA,
Sponsor: AbbVie

Sex: All

Age: 50+

Code: NCT07007065

Phase 3, Recruiting

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

for
Atrial Fibrillation (AF)
Location: Fremont CA, Santa Maria CA, Ventura CA, West Hills CA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07626411

Phase 3, Recruiting

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

for
Atrial Fibrillation (AF)
Location: Fremont CA, Santa Maria CA, Ventura CA, West Hills CA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07430956

Phase 3, Recruiting